Long-term Outcomes of One Stage Surgery Using Transanal Colorectal Tube for Acute Colorectal Obstruction of Stage II/III Distal Colon Cancer.
Long-term Outcomes of One Stage Surgery Using Transanal Colorectal Tube for Acute Colorectal Obstruction of Stage II/III Distal Colon Cancer.
复制标题
一级手术的长期结局,使用跨型结直肠管,用于II/III期远端结肠癌的急性结直肠梗阻。
DOI:
10.4143/crt.2018.059
复制
发表时间:
2019-04
影响因子:
4.6
通讯作者:
Joh T
中科院分区:
文献类型:
--
作者:
Okuda Y;Yamada T;Hirata Y;Shimura T;Yamaguchi R;Sakamoto E;Sobue S;Nakazawa T;Kataoka H;Joh T
Since oncological outcomes of transanal colorectal tube (TCT) placement, an endoscopic treatment for colorectal cancer (CRC) with acute colorectal obstruction (ACO), remain unknown, this study analyzed long-term outcomes of TCT placement for stage II/III CRC with ACO. Data were retrospectively reviewed from consecutive patients with distal stage II/III CRC who underwent surgery between January 2007 and December 2011 at two Japanese hospitals. One hospital conducted emergency surgery and the other performed TCT placement as the standard treatment for all CRCs with ACO. Propensity score (PS) matching was used to adjust baseline characteristics between two groups. Among 754 patients with distal stage II/III CRC, 680 did not have ACO (non-ACO group) and 74 had ACO (ACO group). The PS matching between both hospitals identified 234 pairs in the non-ACO group and 23 pairs in the ACO group. In the non-ACO group, the surgical quality was equivalent between the two institutions, with no significant differences in overall survival (OS) and disease-free survival (DFS). In the ACO group, the rate of primary resection/anastomosis was higher in the TCT group than in the surgery group (87.0% vs. 26.1%, p < 0.001). No significant differences were noted between the surgery and the TCT groups in OS (5-year OS, 61.9% vs. 51.5%; p=0.490) and DFS (5-year DFS, 45.9% vs. 38.3%; p=0.658). TCT placement can achieve similar long-term outcomes to emergency surgery, with a high rate of primary resection/anastomosis for distal stage II/III colon cancer with ACO.
登录
查看更多内容
影响因子:
3.4
作者:
Sjo, O. H.;Larsen, S.;Nesbakken, A.
通讯作者:
Nesbakken, A.
影响因子:
4.3
作者:
Ye, Guang-Yao;Cui, Zhe;Zhong, Ming
通讯作者:
Zhong, Ming
影响因子:
3.9
作者:
Tanaka, T;Furukawa, A;Sakamoto, T
通讯作者:
Sakamoto, T
影响因子:
9.6
作者:
McArdle, CS;McMillan, DC;Hole, DJ
通讯作者:
Hole, DJ
影响因子:
2.6
作者:
Alcantara, M.;Serra-Aracil, X.;Navarro, S.
通讯作者:
Navarro, S.